<DOC>
	<DOCNO>NCT00948558</DOCNO>
	<brief_summary>1 . To compare difference citrate pharmacokinetics healthy individual critically ill patient well influential factor . 2 . To validate pharmacokinetic model establish formal paper . 3 . To create safe effective RCA-CRRT protocol .</brief_summary>
	<brief_title>Citrate Pharmacokinetics Regional Citrate Anticoagulation CRRT</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>healthy individual , nonepregnant diagnose acute renal failure accord RIFLE criterion ARF hepatic insufficiency ARF MODS sepsis within informed consent use drug citrate within one week infuse blood , plasma platelet undergone plasma exchange therapy within 48 hour serious alkalosis PH &gt; 7.55 serious lactic acidosis resuscitation state</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>citrate anticoagulation</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>critically ill</keyword>
	<keyword>acute kidney failure</keyword>
</DOC>